Mohd Hisam Nur Shahirah, Wong Kah Hui
Department of Anatomy, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
Antioxidants (Basel). 2024 Mar 19;13(3):375. doi: 10.3390/antiox13030375.
Spinocerebellar ataxia type 3 (SCA3) is an autosomal dominant neurodegenerative disorder that gives rise to motor incoordination and progressive functional disabilities. Although pharmacological interventions have revealed promising prospects in the management of SCA3, adverse effects may become unbearable. The use of herbal remedies in traditional Chinese medicine (TCM) may serve as potential alternative medicines to delay the progression of the disease. This systematic review is intended to identify, appraise, and summarize the findings of studies pertaining to the therapeutic roles of herbal remedies in TCM targeting oxidative stress in the management of SCA3. A literature search for relevant articles published from 1 January 2013 to 30 June 2023 in three databases, namely PubMed, Web of Science, and Scopus, was carried out according to the procedures of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). A total of ten preclinical studies met the inclusion criteria of the systematic review. We recognized the therapeutic potential of , , sp., , , , , , sp., , , , , and . We identified the types of preclinical models expressing polyglutamine (polyQ) expanded mutant protein (mATXN3), inducers of oxidative stress that mimic the SCA3 pathogenesis, and effective doses of the herbal remedies. The modes of action contributing to the attenuation of oxidative stress are activation of antioxidant pathways, ubiquitin-proteasome system and autophagy, regulation of apoptosis, proinflammatory signaling pathway and chaperones, regulation of mitochondrial function and biogenesis, and restoration of neurotransmission and synaptic plasticity. In conclusion, herbal remedies in TCM may possibly delay the progression of SCA3, therefore providing justification for clinical trials.
脊髓小脑共济失调3型(SCA3)是一种常染色体显性神经退行性疾病,可导致运动不协调和进行性功能残疾。尽管药物干预在SCA3的治疗中显示出了有前景的前景,但不良反应可能变得难以忍受。中药中的草药疗法可能作为潜在的替代药物来延缓疾病的进展。本系统评价旨在识别、评估和总结有关中药草药疗法在SCA3治疗中针对氧化应激的治疗作用的研究结果。根据系统评价和荟萃分析的首选报告项目(PRISMA)程序,在三个数据库,即PubMed、科学网和Scopus中,对2013年1月1日至2023年6月30日发表的相关文章进行了文献检索。共有十项临床前研究符合该系统评价的纳入标准。我们认识到[具体草药名称1]、[具体草药名称2]、[具体植物属名1]、[具体草药名称3]、[具体草药名称4]、[具体草药名称5]、[具体草药名称6]、[具体植物属名2]、[具体草药名称7]、[具体草药名称8]、[具体草药名称9]、[具体草药名称10]、[具体植物属名3]、[具体草药名称11]、[具体草药名称12]、[具体草药名称13]、[具体草药名称14]、[具体草药名称15]、[具体草药名称16]和[具体草药名称17]的治疗潜力。我们确定了表达多聚谷氨酰胺(polyQ)扩展突变蛋白(mATXN3)的临床前模型类型、模拟SCA3发病机制的氧化应激诱导剂以及草药疗法的有效剂量。导致氧化应激减轻的作用模式包括抗氧化途径、泛素 - 蛋白酶体系统和自噬的激活,细胞凋亡、促炎信号通路和伴侣蛋白的调节,线粒体功能和生物发生的调节,以及神经传递和突触可塑性的恢复。总之,中药中的草药疗法可能会延缓SCA3的进展,因此为临床试验提供了依据。